| Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study SH Khoo, R Fitzgerald, T Fletcher, S Ewings, T Jaki, R Lyon, N Downs, ... Journal of Antimicrobial Chemotherapy 76 (12), 3286-3295, 2021 | 125 | 2021 |
| Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs T Burnett, P Mozgunov, P Pallmann, SS Villar, GM Wheeler, T Jaki BMC medicine 18, 1-21, 2020 | 62 | 2020 |
| Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind … SH Khoo, R FitzGerald, G Saunders, C Middleton, S Ahmad, CJ Edwards, ... The Lancet Infectious Diseases 23 (2), 183-195, 2023 | 61 | 2023 |
| Efficient adaptive designs for clinical trials of interventions for COVID-19 N Stallard, L Hampson, N Benda, W Brannath, T Burnett, T Friede, ... Statistics in Biopharmaceutical Research 12 (4), 483-497, 2020 | 61 | 2020 |
| An information-theoretic Phase I/II design for molecularly targeted agents that does not require an assumption of monotonicity P Mozgunov, T Jaki Journal of the Royal Statistical Society: Series C (Applied Statistics) 68 …, 2018 | 27 | 2018 |
| A Benchmark for Dose Finding Studies with Continuous Outcomes P Mozgunov, T Jaki, X Paoletti Biostatistics, 2018 | 23 | 2018 |
| AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised … GO Griffiths, R FitzGerald, T Jaki, A Corkhill, H Reynolds, S Ewings, ... Trials 22, 1-5, 2021 | 22 | 2021 |
| A review of the deterministic and diffusion approximations for stochastic chemical reaction networks P Mozgunov, M Beccuti, A Horvath, T Jaki, R Sirovich, E Bibbona Reaction Kinetics, Mechanisms and Catalysis 123 (2), 289-312, 2018 | 17 | 2018 |
| An information-theoretic approach for selecting arms in clinical trials P Mozgunov, T Jaki Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2020 | 15 | 2020 |
| An open label, adaptive, phase 1 trial of high‐dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS‐CoV‐2 LE Walker, R FitzGerald, G Saunders, R Lyon, M Fisher, K Martin, ... Clinical Pharmacology & Therapeutics 111 (3), 585-594, 2022 | 14 | 2022 |
| A benchmark for dose-finding studies with unknown ordering P Mozgunov, X Paoletti, T Jaki Biostatistics, 2021 | 14 | 2021 |
| Randomized dose-escalation designs for drug combination cancer trials with immunotherapy P Mozgunov, T Jaki, X Paoletti Journal of Biopharmaceutical Statistics 29 (2), 359-377, 2019 | 13 | 2019 |
| Using an Interaction Parameter in Model-Based Phase I Trials for Combination Treatments? A Simulation Study P Mozgunov, R Knight, H Barnett, T Jaki International Journal of Environmental Research and Public Health 18 (1), 345, 2021 | 11 | 2021 |
| A surface-free design for phase I dual-agent combination trials P Mozgunov, M Gasparini, T Jaki Statistical methods in medical research 29 (10), 3093-3109, 2020 | 11 | 2020 |
| Loss functions in restricted parameter spaces and their Bayesian applications P Mozgunov, T Jaki, M Gasparini Journal of Applied Statistics 46 (13), 2314-2337, 2019 | 11 | 2019 |
| Shannon's differential entropy asymptotic analysis in a Bayesian problem M Kelbert, P Mozgunov Mathematical Communications 20 (2), 219-228, 2015 | 8 | 2015 |
| A novel measure of drug benefit–risk assessment based on Scale Loss Score G Saint-Hilary, V Robert, M Gasparini, T Jaki, P Mozgunov Statistical methods in medical research 28 (9), 2738-2753, 2019 | 7 | 2019 |
| A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints P Mozgunov, T Jaki Biometrical Journal 61 (6), 1477-1492, 2019 | 6 | 2019 |
| Generalization of Cramér-Rao and Bhattacharyya inequalities for the weighted covariance matrix M Kelbert, P Mozgunov Mathematical Communications 22 (1), 25-40, 2017 | 6 | 2017 |
| Asymptotic behaviour of the weighted Renyi, Tsallis and Fisher entropies in a Bayesian problem MY Kelbert, PA Mozgunov Eurasian Mathematical Journal 6 (2), 6-17, 2015 | 6 | 2015 |
Thomas JakiProfessor of Statistics, University of Regensburg and University of CambridgeVerified email at ur.de
